KAYTERIX Trademark

Trademark Overview


On Monday, August 14, 2023, a trademark application was filed for KAYTERIX with the United States Patent and Trademark Office. The USPTO has given the KAYTERIX trademark a serial number of 98131259. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Saturday, November 1, 2025. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The KAYTERIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain
kayterix

General Information


Serial Number98131259
Word MarkKAYTERIX
Filing DateMonday, August 14, 2023
Status732 - THIRD EXTENSION - GRANTED
Status DateSaturday, November 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events


Event DateEvent Description
Thursday, August 17, 2023NEW APPLICATION ENTERED
Tuesday, September 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 23, 2024ASSIGNED TO EXAMINER
Monday, February 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 22, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 22, 2024SOU EXTENSION 1 FILED
Tuesday, October 22, 2024SOU EXTENSION 1 GRANTED
Tuesday, October 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 1, 2025SOU TEAS EXTENSION RECEIVED
Friday, May 2, 2025SOU EXTENSION 2 FILED
Friday, May 2, 2025SOU EXTENSION 2 GRANTED
Friday, May 2, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 30, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 30, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 31, 2025SOU TEAS EXTENSION RECEIVED
Friday, October 31, 2025SOU EXTENSION 3 FILED
Saturday, November 1, 2025SOU EXTENSION 3 GRANTED
Saturday, November 1, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED